Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Olivier Hermine

Showing results (1-10 of 680) with videos related to

Pageof 68
Sort By:
Leukemia & Lymphoma|December 29, 2004
In vivo and in vitro treatment of HTLV-1 and HTLV-2 infected cells with arsenic trioxide and interferon-alphaRenaud Mahieux, Olivier Hermine
Current Opinion in Oncology|July 12, 2011
Extranodal natural killer/T-cell lymphoma: advances in the managementArnaud Jaccard, Olivier Hermine
Joint Bone Spine|November 3, 2012
Mast cells and inflammationLaurent Frenzel, Olivier Hermine
Transfusion|March 29, 2014
The real superdonorsJean-Jacques Lefrère, Olivier Hermine
Blood|October 24, 2015
Erythroferrone: the missing link in β-thalassemia?Ivan C Moura, Olivier Hermine
Medicine|November 28, 2023
Diagnostic challenges and updated therapeutic strategies of Kimura's disease: A case report successfully treated by dupilumab and reviewStephanie Cordeil, Olivier Hermine, Arnaud Hot
Frontiers in Allergy|November 27, 2025
From mechanism to management: CEREMAST perspectives on the intersection of HαT and clonal mast cell disordersLaura Polivka, Olivier Hermine, Julien Rossignol
Frontiers in Immunology|January 22, 2019
Epstein-Barr Virus (EBV)-Related Lymphoproliferative Disorders in Ataxia Telangiectasia: Does ATM Regulate EBV Life Cycle?Moussab Tatfi, Olivier Hermine, Felipe Suarez
Current Hematologic Malignancy Reports|September 7, 2016
Activin Receptor II Ligand Traps and Their Therapeutic Potential in Myelodysplastic Syndromes with Ring SideroblastsAnna Mies, Olivier Hermine, Uwe Platzbecker
Frontiers in Medicine|August 5, 2017
Targeted Treatment Options in MastocytosisMélanie Vaes, Fleur Samantha Benghiat, Olivier Hermine
Pageof 68

Showing results (1-10 of 680) with videos related to

Sort By:
Pageof 68
Leukemia & Lymphoma|December 29, 2004
In vivo and in vitro treatment of HTLV-1 and HTLV-2 infected cells with arsenic trioxide and interferon-alphaRenaud Mahieux, Olivier Hermine
Current Opinion in Oncology|July 12, 2011
Extranodal natural killer/T-cell lymphoma: advances in the managementArnaud Jaccard, Olivier Hermine
Joint Bone Spine|November 3, 2012
Mast cells and inflammationLaurent Frenzel, Olivier Hermine
Transfusion|March 29, 2014
The real superdonorsJean-Jacques Lefrère, Olivier Hermine
Blood|October 24, 2015
Erythroferrone: the missing link in β-thalassemia?Ivan C Moura, Olivier Hermine
Medicine|November 28, 2023
Diagnostic challenges and updated therapeutic strategies of Kimura's disease: A case report successfully treated by dupilumab and reviewStephanie Cordeil, Olivier Hermine, Arnaud Hot
Frontiers in Allergy|November 27, 2025
From mechanism to management: CEREMAST perspectives on the intersection of HαT and clonal mast cell disordersLaura Polivka, Olivier Hermine, Julien Rossignol
Frontiers in Immunology|January 22, 2019
Epstein-Barr Virus (EBV)-Related Lymphoproliferative Disorders in Ataxia Telangiectasia: Does ATM Regulate EBV Life Cycle?Moussab Tatfi, Olivier Hermine, Felipe Suarez
Current Hematologic Malignancy Reports|September 7, 2016
Activin Receptor II Ligand Traps and Their Therapeutic Potential in Myelodysplastic Syndromes with Ring SideroblastsAnna Mies, Olivier Hermine, Uwe Platzbecker
Frontiers in Medicine|August 5, 2017
Targeted Treatment Options in MastocytosisMélanie Vaes, Fleur Samantha Benghiat, Olivier Hermine
Pageof 68